• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. PS TIBIAL INSERTS SZ 3, 11MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. PS TIBIAL INSERTS SZ 3, 11MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 204-23-11
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Osteolysis (2377); Joint Laxity (4526)
Date of Event 06/17/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D10: concomitants: 204-04-34 - trapezoid tibial tray sz 3f/4t.234-03-03 - optetrak asy, ps cemented.Should additional relevant information be obtained, a follow-up mdr will be submitted accordingly.
 
Event or Problem Description
It was reported that a patient, who had an initial right knee implanted, underwent a revision procedure.The surgeon performed a synovectomy surrounding the affected knee.Severe osteolysis present.Severe damage to the tibial insert.Upon further inspection, the femoral component had loosened.All components were removed and revised to another system.There were no surgical delays or device breakages reported.The patient was last known to be in stable condition following the event.No x-rays were able to be obtained.The explanted devices are not available for return.The hospital retained them for analysis.Device images were provided.No further information is available.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.The following sections were updated: h3, h6, h11.This is 1 of 2 reports.According to the information provided, all components were removed and revised to another system.Severe damage to the tibial insert and the femoral component had loosened were reported.No device was returned for evaluation; photographs of the device were provided; however, the reported event was unable to be confirmed.The review identified the image of the femoral component appeared unremarkable for an explanted component.The articular surface of the tibial insert appears to be worn with areas of pitting.The pitting may be related to delamination and/or third body wear.Additionally, the damage appears to be primarily on the anterior aspect of the articular surface and there also appears to be notching on the anterior portion of the tibial insert spine.The wear pattern may suggest relative hyperextension of the joint and/or ap instability.There also appears to be deformation and/or wear to the posterior aspect of the tibial insert spine.This may indicate higher-than-normal shear forces and rapid, rather than gradual, engagement of the femoral cam with the tibial insert spine during knee flexion.There appears to be some minor burnishing marks on the mating surface of the tibial tray.This was likely due to micromotion between the insert and the tray.The device otherwise appears unremarkable for an explanted component.A review of complaint history determined that no further action is required as no trends were identified.The revision reported may have been the result of femoral loosening and tibial insert wear with subsequent osteolysis.The wear may be related to orientation of the components and/or joint instability.However, the reasons for the wear and the reported loosening could not be confirmed because the devices were not available for evaluation and no radiographs were provided.Additionally, manufacturing and patient related contributions could not be assessed based on the available information.Should additional relevant information be obtained, a follow-up mdr will be submitted accordingly.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional and/or corrected information.The following sections were updated/corrected: d1, h6.Mdr section codes updated/corrected: e.The revision reported may have been the result of femoral loosening and tibial insert wear with subsequent osteolysis.The wear may be related to orientation of the components and/or joint instability.However, the reasons for the wear and the reported loosening could not be confirmed because the devices were not available for evaluation and no radiographs were provided.Additionally, manufacturing and patient related contributions could not be assessed based on the available information.Should additional relevant information be obtained, a follow-up mdr will be submitted accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PS TIBIAL INSERTS SZ 3, 11MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer Contact
geoff gannon
2320 nw 66 court
gainesville, FL 32653
3525541928
MDR Report Key22661285
Report Number1038671-2025-02632
Device Sequence Number11687838
Product Code JWH
UDI-Device Identifier10885862048318
UDI-Public10885862048318
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K933610
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number204-23-11
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2025
Supplement Date Received by Manufacturer11/04/2025
11/04/2025
Initial Report FDA Received Date07/30/2025
Supplement Report FDA Received Date11/10/2025
11/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-